Acromegaly pathophysiology: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
 
(15 intermediate revisions by 3 users not shown)
Line 4: Line 4:


==Overview==
==Overview==
Acromegaly pathogenesis depends mainly on the excessive secretion of the [[growth hormone]] from the [[pituitary gland]]. [[Pituitary adenoma|Pituitary somatotroph cell adenoma]] leads to hyper-secretion of the growth hormone. [[Insulin-like growth factor]] 1 (IGF-1) inhibits the secretion of [[growth hormone]] in two ways. [[IGF-1]] inhibits directly the [[Somatotrophs|somatotroph cells]] or stimulates secretion the [[somatostatin]] that inhibits the [[GH]] secretion. The IGF-1 is responsible for the acral features of the acromegaly. The  [[IGF-1]] causes the rapid increase in the [[hand]] and [[feet]] size, [[forehead]] protrusion, and [[jaw]] prominence. A [[genetic mutation]] in the alpha subunit of the [[guanine]] nucleotide stimulatory [[protein]] leads to increase synthesis of [[cAMP]] which increases the secretion of [[growth hormone]]. Acromegaly is associated with [[Multiple endocrine neoplasia type 1|Multiple Endocrine Neoplasia 1 (MEN-1)]], [[Carney complex|Carney complex,]] [[McCune-Albright syndrome]][[Paraganglioma|, paraganglioma,]] and [[Pheochromocytoma]].  
Acromegaly pathogenesis depends mainly on the excessive secretion of the [[growth hormone]] from the [[pituitary gland]]. [[Pituitary adenoma|Pituitary somatotroph cell adenoma]] leads to hyper-secretion of the [[growth hormone]]. [[Insulin-like growth factor|Insulin-like growth factor 1 (IGF-1)]] inhibits the secretion of [[growth hormone]] in two ways: [[IGF-1]] inhibits directly the [[Somatotrophs|somatotroph cells]] or stimulates secretion the [[somatostatin]] that inhibits the [[GH]] secretion, IGF-1 is also responsible for the acral features of the acromegaly. The  [[IGF-1]] causes the rapid increase in the [[hand]] and [[feet]] size, [[forehead]] protrusion, and [[jaw]] prominence. A [[genetic mutation]] in the alpha subunit of the [[guanine]] nucleotide stimulatory [[protein]] leads to increase synthesis of [[cAMP]] which increases the secretion of [[growth hormone]]. Acromegaly is associated with [[Multiple endocrine neoplasia type 1|multiple endocrine neoplasia 1 (MEN-1)]], [[Carney complex|Carney complex,]] [[McCune-Albright syndrome]][[Paraganglioma|, paraganglioma,]] and [[Pheochromocytoma]].  


==Pathophysiology==
==Pathophysiology==
Acromegaly is believed to be caused by [[GH|growth hormone (GH)]] secreting [[pituitary adenomas]] either [[Microadenoma of the pituitary gland|microadenomas]] or [[Macroadenoma of the pituitary gland|macroadenomas]]. The [[pituitary adenoma]] leads to hypersecretion of the [[growth hormone]] from the [[Somatotrophs|somatotroph cells]].<ref name="pmid26873451">{{cite journal| author=Dineen R, Stewart PM, Sherlock M| title=Acromegaly. | journal=QJM | year= 2016 | volume=  | issue=  | pages=  | pmid=26873451 | doi=10.1093/qjmed/hcw004 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26873451  }} </ref><ref name="pmid2549426">{{cite journal| author=Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L| title=GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. | journal=Nature | year= 1989 | volume= 340 | issue= 6236 | pages= 692-6 | pmid=2549426 | doi=10.1038/340692a0 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2549426  }} </ref><ref name="pmid19884662">{{cite journal| author=Melmed S| title=Acromegaly pathogenesis and treatment. | journal=J Clin Invest | year= 2009 | volume= 119 | issue= 11 | pages= 3189-202 | pmid=19884662 | doi=10.1172/JCI39375 | pmc=2769196 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19884662  }}</ref>


===Normal Physiology===
*Normally, the [[growth hormone]] is secreted and stored in the [[anterior pituitary gland]] particularly in the [[Somatotrophs|somatotroph cells]].
*[[Growth hormone]] secretion is affected by several factors.
**[[Growth hormone]] is stimulated by [[ghrelin]] and [[growth hormone releasing hormone]].
**[[Somatostatin]] inhibits the [[growth hormone]] secretion.
*[[Insulin-like growth factor]] 1 (IGF-1) inhibits the secretion of [[growth hormone]] in two ways.
**IGF-1 inhibits directly the [[Somatotrophs|somatotroph cells]] or stimulates secretion the [[somatostatin]] that inhibits the [[GH]] secretion.
*[[Growth hormone]] is functioning through binding to its receptor which is a [[glycoprotein]] receptor.
*Binding of [[GH]] to its receptor stimulates [[proteins]] which start a process called signal [[transduction]] and [[transcription]].
=== Pathogenesis ===
=== Pathogenesis ===
*It is thought that acromegaly caused by [[GH]] secreting [[pituitary adenomas]] either [[Microadenoma of the pituitary gland|microadenomas]] or [[Macroadenoma of the pituitary gland|macroadenomas]]. The pituitary adenoma leads to hypersecretion of the [[growth hormone]] from the [[Somatotrophs|somatotroph cells]].
*In [[pituitary adenomas]], a [[mutation]] in the alpha subunit of the [[Guanine|guanine nucleotide]] stimulatory [[protein]] is responsible for the excess [[growth hormone]] secretion.  
*Normally, the [[growth hormone]] is secreted and stored in the [[anterior pituitary gland]] particularly in the [[Somatotrophs|somatotroph cells]].  [[growth hormone]] secretion is affected by several factors. [[growth hormone]] is stimulated by [[ghrelin]] and [[growth hormone releasing hormone]]. [[Somatostatin]] inhibits the [[growth hormone]] secretion.<ref name="pmid26873451">{{cite journal| author=Dineen R, Stewart PM, Sherlock M| title=Acromegaly. | journal=QJM | year= 2016 | volume=  | issue=  | pages=  | pmid=26873451 | doi=10.1093/qjmed/hcw004 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26873451  }} </ref>
*The mutation in the alpha subunit will lead to increase synthesis of [[cAMP]] which is responsible for the growth of certain cells.
*[[Insulin-like growth factor]] 1 (IGF-1) inhibits the secretion of [[growth hormone]] in two ways. IGF-1 inhibits directly the [[Somatotrophs|somatotroph cells]] or stimulates secretion the [[somatostatin]] that inhibits the [[GH]] secretion.  
*Increase synthesis of [[cAMP]] will result in the increase secretion of the [[growth hormone]].
*[[Growth hormone]] is functioning through binding to its receptor which is a [[glycoprotein]] receptor. Binding of [[GH]] to its receptor stimulates [[proteins]] which start a process called signal [[transduction]] and [[transcription]]. Signal transduction and transcription (STAT) induce production of [[IGF-1]] from [[liver]], [[bone]] and [[pituitary gland]].<ref name="pmid19884662">{{cite journal| author=Melmed S| title=Acromegaly pathogenesis and treatment. | journal=J Clin Invest | year= 2009 | volume= 119 | issue= 11 | pages= 3189-202 | pmid=19884662 | doi=10.1172/JCI39375 | pmc=2769196 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19884662  }}</ref>
*Signal transduction and transcription (STAT) induce production of [[IGF-1]] from [[liver]], [[bone]] and [[pituitary gland]].  
*The [[IGF-1]] is responsible for the acral features of acromegaly. [[IGF-1]] causes the rapid increase in the [[hand]] and [[feet]] size, [[forehead]] protrusion, and [[jaw]] prominence.
*The [[IGF-1]] is responsible for the acral features of acromegaly. [[IGF-1]] causes the rapid increase in the [[hand]] and [[feet]] size, [[forehead]] protrusion, and [[jaw]] prominence.
*The high level of [[IGF-1]] is responsible for the following pathologic processes:  
*The high level of [[IGF-1]] is responsible for the following pathologic processes:  
Line 19: Line 29:


==Genetics==
==Genetics==
*The development of acromegaly is the result of multiple [[genetic mutations]]. In [[pituitary adenomas]], a [[mutation]] in the alpha subunit of the [[Guanine|guanine nucleotide]] stimulatory [[protein]] is responsible for the excess [[growth hormone]] secretion. The mutation in the alpha subunit will lead to increase synthesis of [[cAMP]] which is responsible for the growth of certain cells. Increase synthesis of [[cAMP]] will result in the increase secretion of the [[growth hormone]].<ref name="pmid2549426">{{cite journal| author=Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L| title=GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. | journal=Nature | year= 1989 | volume= 340 | issue= 6236 | pages= 692-6 | pmid=2549426 | doi=10.1038/340692a0 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2549426  }} </ref>
*The development of acromegaly has been associated also with microduplications on [[chromosome]] Xq26.3 which is a location for [[G protein]] coupled receptor 101 [[gene]] (GPCR101).
*The development of acromegaly has been associated also with microduplications on [[chromosome]] Xq26.3 which is a location for [[G protein]] coupled receptor 101 [[gene]] (GPCR101). Microduplication of the chromosome Xq26.3 will be associated with mutations of the GPCR101 protein which leads to increase of the [[growth hormone]] secretion.<ref name="pmid25470569">{{cite journal| author=Trivellin G, Daly AF, Faucz FR, Yuan B, Rostomyan L, Larco DO et al.| title=Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation. | journal=N Engl J Med | year= 2014 | volume= 371 | issue= 25 | pages= 2363-74 | pmid=25470569 | doi=10.1056/NEJMoa1408028 | pmc=4291174 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25470569  }} </ref>
*Microduplication of the chromosome Xq26.3 will be associated with mutations of the GPCR101 protein which leads to increase of the [[growth hormone]] secretion.<ref name="pmid25470569">{{cite journal| author=Trivellin G, Daly AF, Faucz FR, Yuan B, Rostomyan L, Larco DO et al.| title=Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation. | journal=N Engl J Med | year= 2014 | volume= 371 | issue= 25 | pages= 2363-74 | pmid=25470569 | doi=10.1056/NEJMoa1408028 | pmc=4291174 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25470569  }} </ref>


==Associated Conditions==
==Associated Conditions==
*Patients with acromegaly may be associated with the following genetic diseases:<ref name="pmid27657986">{{cite journal| author=Hannah-Shmouni F, Trivellin G, Stratakis CA| title=Genetics of gigantism and acromegaly. | journal=Growth Horm IGF Res | year= 2016 | volume= 30-31 | issue=  | pages= 37-41 | pmid=27657986 | doi=10.1016/j.ghir.2016.08.002 | pmc=5154831 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27657986  }} </ref>
*Acromegaly may be associated with the following genetic diseases:<ref name="pmid27657986">{{cite journal| author=Hannah-Shmouni F, Trivellin G, Stratakis CA| title=Genetics of gigantism and acromegaly. | journal=Growth Horm IGF Res | year= 2016 | volume= 30-31 | issue=  | pages= 37-41 | pmid=27657986 | doi=10.1016/j.ghir.2016.08.002 | pmc=5154831 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27657986  }} </ref>
**Familial isolated [[pituitary adenoma]]
**Familial isolated [[pituitary adenoma]]
**[[Multiple endocrine neoplasia type 1|Multiple Endocrine Neoplasia 1 (MEN-1)]]  
**[[Multiple endocrine neoplasia type 1|Multiple Endocrine Neoplasia 1 (MEN-1)]]  
Line 30: Line 40:
**[[Paraganglioma]]
**[[Paraganglioma]]
**[[Pheochromocytoma]]
**[[Pheochromocytoma]]
*Patients with acromegaly may be associated with the following conditions:<ref name="pmid25356808">{{cite journal| author=Katznelson L, Laws ER, Melmed S, Molitch ME, Murad MH, Utz A et al.| title=Acromegaly: an endocrine society clinical practice guideline. | journal=J Clin Endocrinol Metab | year= 2014 | volume= 99 | issue= 11 | pages= 3933-51 | pmid=25356808 | doi=10.1210/jc.2014-2700 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25356808  }} </ref>
**[[Diabetes mellitus]]  
**[[Diabetes mellitus]]  
**[[Sleep apnea]]  
**[[Sleep apnea]]  
Line 37: Line 45:
**[[Hypertension]]  
**[[Hypertension]]  
**[[Osteoarthritis]]
**[[Osteoarthritis]]
== Gross pathology ==
Gross pathology of acromegaly shows [[pituitary gland]] [[adenoma]] in most of the cases. Findings include the following:
*Microprolactinomas (<10mm size) are usually found in the lateral wing of the pituitary gland. They are most often surrounded by well defined pseudocapsules composed of reticulin.
*Macroprolactinomas (>10mm size) differ substantially in size and behavior. Some cause sellar expansion while others invade the base of the skull.
*About 50% of all prolactinoma grossly invade surrounding structures.
==Microscopic pathology==
*Pituitary microadenomas are defined as adenomas less than 10 mm in size.
*Most frequently diagnosed as a result of investigating hormonal imbalance.
*They are confined to the [[sella]] and have no scope to produce mass effect related symptoms.
<gallery>
Pituitary adenoma (1) GH production.jpg|Histopathological image of pituitary adenoma with GH production. Acidophilic cell type. Hematoxylin & esoin stain.<ref name=Wikipedia1> https://en.wikipedia.org/wiki/Pituitary_adenoma#/media/File:Pituitary_adenoma_%281%29_GH_production.jpg</ref>
Image:
Pituitary adenoma (2) GH production.jpg|Histopathological image of pituitary adenoma with GH production. Acidophilic cell type. Hematoxylin & esoin stain.<ref name=Wikipedia1> https://en.wikipedia.org/wiki/Pituitary_adenoma#/media/File:Pituitary_adenoma_%281%29_GH_production.jpg</ref>
</gallery>


==References==
==References==

Latest revision as of 12:14, 5 February 2018

Acromegaly Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acromegaly from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Radiation Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acromegaly pathophysiology On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acromegaly pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acromegaly pathophysiology

CDC on Acromegaly pathophysiology

Acromegaly pathophysiology in the news

Blogs on Acromegaly pathophysiology

Directions to Hospitals Treating Acromegaly

Risk calculators and risk factors for Acromegaly pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]

Overview

Acromegaly pathogenesis depends mainly on the excessive secretion of the growth hormone from the pituitary gland. Pituitary somatotroph cell adenoma leads to hyper-secretion of the growth hormone. Insulin-like growth factor 1 (IGF-1) inhibits the secretion of growth hormone in two ways: IGF-1 inhibits directly the somatotroph cells or stimulates secretion the somatostatin that inhibits the GH secretion, IGF-1 is also responsible for the acral features of the acromegaly. The IGF-1 causes the rapid increase in the hand and feet size, forehead protrusion, and jaw prominence. A genetic mutation in the alpha subunit of the guanine nucleotide stimulatory protein leads to increase synthesis of cAMP which increases the secretion of growth hormone. Acromegaly is associated with multiple endocrine neoplasia 1 (MEN-1), Carney complex, McCune-Albright syndrome, paraganglioma, and Pheochromocytoma.

Pathophysiology

Acromegaly is believed to be caused by growth hormone (GH) secreting pituitary adenomas either microadenomas or macroadenomas. The pituitary adenoma leads to hypersecretion of the growth hormone from the somatotroph cells.[1][2][3]

Normal Physiology

Pathogenesis

Genetics

  • The development of acromegaly has been associated also with microduplications on chromosome Xq26.3 which is a location for G protein coupled receptor 101 gene (GPCR101).
  • Microduplication of the chromosome Xq26.3 will be associated with mutations of the GPCR101 protein which leads to increase of the growth hormone secretion.[4]

Associated Conditions

Gross pathology

Gross pathology of acromegaly shows pituitary gland adenoma in most of the cases. Findings include the following:

  • Microprolactinomas (<10mm size) are usually found in the lateral wing of the pituitary gland. They are most often surrounded by well defined pseudocapsules composed of reticulin.
  • Macroprolactinomas (>10mm size) differ substantially in size and behavior. Some cause sellar expansion while others invade the base of the skull.
  • About 50% of all prolactinoma grossly invade surrounding structures.

Microscopic pathology

  • Pituitary microadenomas are defined as adenomas less than 10 mm in size.
  • Most frequently diagnosed as a result of investigating hormonal imbalance.
  • They are confined to the sella and have no scope to produce mass effect related symptoms.
  • Histopathological image of pituitary adenoma with GH production. Acidophilic cell type. Hematoxylin & esoin stain.[6]

    Histopathological image of pituitary adenoma with GH production. Acidophilic cell type. Hematoxylin & esoin stain.[6]

  • Histopathological image of pituitary adenoma with GH production. Acidophilic cell type. Hematoxylin & esoin stain.[6]

    Histopathological image of pituitary adenoma with GH production. Acidophilic cell type. Hematoxylin & esoin stain.[6]

References

  1. ↑ Dineen R, Stewart PM, Sherlock M (2016). "Acromegaly". QJM. doi:10.1093/qjmed/hcw004. PMID 26873451.
  2. ↑ Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L (1989). "GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours". Nature. 340 (6236): 692–6. doi:10.1038/340692a0. PMID 2549426.
  3. ↑ Melmed S (2009). "Acromegaly pathogenesis and treatment". J Clin Invest. 119 (11): 3189–202. doi:10.1172/JCI39375. PMC 2769196. PMID 19884662.
  4. ↑ Trivellin G, Daly AF, Faucz FR, Yuan B, Rostomyan L, Larco DO; et al. (2014). "Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation". N Engl J Med. 371 (25): 2363–74. doi:10.1056/NEJMoa1408028. PMC 4291174. PMID 25470569.
  5. ↑ Hannah-Shmouni F, Trivellin G, Stratakis CA (2016). "Genetics of gigantism and acromegaly". Growth Horm IGF Res. 30-31: 37–41. doi:10.1016/j.ghir.2016.08.002. PMC 5154831. PMID 27657986.
  6. ↑ 6.0 6.1 https://en.wikipedia.org/wiki/Pituitary_adenoma#/media/File:Pituitary_adenoma_%281%29_GH_production.jpg

Template:WS Template:WH

Retrieved from "https://www.wikidoc.org/index.php?title=Acromegaly_pathophysiology&oldid=1438298"